Literature DB >> 16336336

Impact of overactive bladder symptoms on employment, social interactions and emotional well-being in six European countries.

Debra E Irwin1, Ian Milsom, Zoe Kopp, Paul Abrams, Linda Cardozo.   

Abstract

OBJECTIVE: To determine the impact of overactive bladder (OAB) symptoms on issues related to employment, social interactions, and emotional well-being in a population aged 40-64 years. SUBJECTS AND METHODS: The study comprised a cross-sectional population-based survey of 11 521 individuals aged 40-64 years, conducted in France, Germany, Italy, Spain, Sweden, and the UK. The survey involved a two-stage screening procedure. Initially, individuals with any lower urinary tract symptoms were identified. Those whose only symptom/(s) was suggestive of a urinary tract infection, stress incontinence, or prostate obstruction were excluded from further study. Respondents were asked questions about the impact that their symptoms had on their emotional well-being, social interactions and productivity at home and at work.
RESULTS: Of those with OAB, approximately 32% (1272) reported that having these symptoms made them feel depressed, and 28% reported feeling very stressed. There were statistically significant differences in reported feelings of stress and depression when OAB symptoms were stratified by OAB with incontinence (OAB+) vs those with OAB with no incontinence (OAB-), with values for emotional stress of OAB+ 36.4% vs OAB- 19.6%, for depression of OAB+ 39.8% vs OAB- 23.3%. Participants with OAB+ were significantly more likely than those with OAB- to express worry about having accidents and concern about participating in activities away from home because of their bladder symptoms. In addition, those with OAB+ were significantly more likely to report that these bladder symptoms were a source of great concern and made them feel uncomfortable in social situations compared to those with OAB-. Men were significantly more likely than women to report OAB+ having an impact on their daily work life, including worry about interrupting meetings, impact on decisions about work location and hours, and voluntary termination or early retirement. This effect was primarily in men reporting OAB+.
CONCLUSION: OAB symptoms have a significant effect on the emotional well-being and productivity of those affected, both at home and at work.

Entities:  

Mesh:

Year:  2006        PMID: 16336336     DOI: 10.1111/j.1464-410X.2005.05889.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  69 in total

1.  Once-daily trospium chloride 60 mg extended release in subjects with overactive bladder syndrome who use multiple concomitant medications: Post hoc analysis of pooled data from two randomized, placebo-controlled trials.

Authors:  Peter K Sand; Eric S Rovner; Jonathan H Watanabe; Michael G Oefelein
Journal:  Drugs Aging       Date:  2011-02-01       Impact factor: 3.923

2.  Are commonly used psychoactive medications associated with lower urinary tract symptoms?

Authors:  Susan A Hall; Nancy N Maserejian; Carol L Link; William D Steers; John B McKinlay
Journal:  Eur J Clin Pharmacol       Date:  2011-12-04       Impact factor: 2.953

3.  Long-term safety, tolerability and efficacy of fesoterodine in subjects with overactive bladder symptoms stratified by age: pooled analysis of two open-label extension studies.

Authors:  Peter K Sand; John Heesakkers; Stephen R Kraus; Martin Carlsson; Zhonghong Guan; Sandra Berriman
Journal:  Drugs Aging       Date:  2012-02-01       Impact factor: 3.923

4.  Genetic influences are important for most but not all lower urinary tract symptoms: a population-based survey in a cohort of adult Swedish twins.

Authors:  Anna-Lena Wennberg; Daniel Altman; Cecilia Lundholm; Asa Klint; Anastasia Iliadou; Ralph Peeker; Magnus Fall; Nancy L Pedersen; Ian Milsom
Journal:  Eur Urol       Date:  2011-03-21       Impact factor: 20.096

5.  Time-to-effect with darifenacin in overactive bladder: a pooled analysis.

Authors:  Vik Khullar; Jenelle Foote; Yodit Seifu; Mathias Egermark
Journal:  Int Urogynecol J       Date:  2011-10-18       Impact factor: 2.894

6.  Triple therapy in refractory detrusor overactivity: a preliminary study.

Authors:  Ricardo Natalin; Leonardo Oliveira Reis; Cristiano Alpendre; Lia Y Ikari; Alessandro Prudente; Carlos A L D'Ancona
Journal:  World J Urol       Date:  2009-03-18       Impact factor: 4.226

7.  Current medical therapies for men with lower urinary tract symptoms and benign prostatic hyperplasia: achievements and limitations.

Authors:  Claus G Roehrborn
Journal:  Rev Urol       Date:  2008

Review 8.  Regenerative medicine based applications to combat stress urinary incontinence.

Authors:  Hatim Thaker; Arun K Sharma
Journal:  World J Stem Cells       Date:  2013-10-26       Impact factor: 5.326

9.  Assessment of female prevalence of overactive bladder (OAB) in Barcelona using a self-administered screening questionnaire: the Cuestionario de Autoevaluación del Control de la Vejiga (CACV).

Authors:  Félix Lugo Salcedo; Rafael Sánchez Borrego
Journal:  Int Urogynecol J       Date:  2013-02-27       Impact factor: 2.894

Review 10.  Practical aspects of lifestyle modifications and behavioural interventions in the treatment of overactive bladder and urgency urinary incontinence.

Authors:  J F Wyman; K L Burgio; D K Newman
Journal:  Int J Clin Pract       Date:  2009-07-02       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.